Nuclear imaging of rheumatic diseases

Area of Science:

• Medical Imaging
• Rheumatology
• Nuclear Medicine

Background:

• Early diagnosis of inflammatory rheumatic diseases is crucial to prevent irreversible tissue damage.
• Current diagnostic methods may lack the sensitivity to detect subclinical inflammation.
• Individualized, cost-effective treatment protocols with optimal therapeutic effects are increasingly needed.

Purpose of the Study:

• To provide an overview of nuclear imaging techniques for rheumatic diseases.
• To discuss recent technical developments in nuclear imaging.
• To highlight the role of these techniques in diagnosis and therapy monitoring.

Main Methods:

• Review of currently available nuclear imaging techniques.
• Discussion of recent technical advancements.
• Focus on positron emission tomography (PET) for its sensitivity and quantitative capabilities.

Main Results:

• Nuclear imaging techniques show potential for early detection of subclinical inflammation in rheumatic diseases.
• Positron emission tomography provides sensitive, quantitative, molecular-level imaging of inflammatory processes.
• These techniques can help image therapeutic targets and monitor disease activity changes.

Conclusions:

• Nuclear imaging, particularly PET, is a valuable tool for the early diagnosis and monitoring of rheumatic diseases.
• Advanced nuclear imaging can guide individualized treatment strategies.
• These methods are essential for managing rheumatic diseases and preventing long-term damage.